Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Current Pharmaceutical Design|May 29, 2003
Clinical trials targeting advanced cancers by active immunization of T-cell defined tumor antigensHideyuki IkedaJournal of Separation Science|April 8, 2010
Detection of the reduced forms of radical adducts on the ESR trace using HPLC-electrochemical detector-ultraviolet absorption detector-electron spin resonance-MSHideyuki Ikeda, Hideo IwahashiJournal of Clinical Biochemistry and Nutrition|May 13, 2011
Caffeic acid inhibits the formation of 1-hydroxyethyl radical in the reaction mixture of rat liver microsomes with ethanol partly through its metal chelating activityHideyuki Ikeda, Yuka Kimura, Miho Masaki, et al.Leukemia & Lymphoma|April 12, 2003
Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignanciesMaiko Matsushita, Rie Yamazaki, Hideyuki Ikeda, et al.The Journal of Dermatology|December 20, 2005
Cardio-facio-cutaneous syndrome: two cases in the same generationHideyuki Ikeda, Atsushi Hatamochi, Hiroshi Okita, et al.The Journal of Dermatology|May 6, 2006
Syringocystadenoma papilliferum associated with apocrine poromaToshihiro Suzuki, Hideyuki Ikeda, Yoichiro Hamasaki, et al.Case Reports in Pediatrics|May 20, 2021
Thoracic Empyema Secondary to Congenital Chylothorax in a 14-Month-Old Boy with Noonan SyndromeTakeru Oikawa, Chiharu Ota, Shinya Iwasawa, et al.The Journal of Dermatology|March 19, 2008
Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areataYayoi Shimaoka, Atsushi Hatamochi, Yoichiro Hamasaki, et al.Journal of Dermatological Science|November 27, 2007
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblastsHideyuki Ikeda, Toshiaki Sunazuka, Hiromi Suzuki, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomasTakayuki Kanaseki, Hideyuki Ikeda, Yukio Takamura, et al.Pageof 6